Table 2.
End-to-end coaptation.
| Treatment | Author | Pub. date | Nerves with follow-up | Age (mean) | Age (range) | Follow-up time (mean) | Follow-up time (range) | Timing of repair | S0–S3 in % | S3+ in % | S4 in % | Glickman and Mackinnon [25] |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| End-to-end coaptation | Larsen | 1958 | 142 | — | — | — | 1–7 y | All | 36 | 64 | 0 | + |
| Weckesser | 1961 | 24 | — | 7–55 y | — | — | All | 24 | 32 | 44 | + | |
| Onne | 1962 | 8 | — | <14 y | — | 4–15 y | Prim. | 0 | 0 | 100 | + | |
| Onne | 1962 | 14 | — | >14 y | — | 4–15 y | Prim. | 57 | 43 | 0 | + | |
|
| ||||||||||||
| Since 1965 surgical microscope | ||||||||||||
| Buncke | 1972 | 18 | — | 6–51 y | — | — | All | 22 | 28 | 50 | + | |
| Poppin | 1979 | 62 | — | 6–67 y | — | 5–15 y | Prim. | 26 | 55 | 19 | + | |
| Posch | 1980 | 71 | — | — | — | 2–11 y | Prim. | 52 | 48 | 0 | + | |
| Young | 1981 | 27 | — | 3–67 y | — | 2–4 y | Prim. | 10 | 57 | 33 | + | |
| Vahvanen* | 1981 | 18 | 9.5 y | 1–14 y | 7.5 y | 2–18 y | All | 0 | 23 | 77 | ||
| Sullivan | 1985 | 42 | — | 20–65 y | 2 y | 0.5–8.5 y | All | 26 | 52 | 22 | ||
| Berger | 1988 | 129 | — | — | 2 y | — | Prim. | 9 | 91 | + | ||
| Mailänder | 1988 | 113 | — | 1–80 y | 2 y | 0.5–5 y | All | 31 | 47 | 22 | ||
| Chiu | 1990 | 12 | 37 y | 19–61 y | 1.8 y | 0.5–3.7 y | — | 0 | 75 | 25 | ||
| Pereira | 1991 | 29 | 38 y | 13–72 y | 2.3 y | 0.7–5.3 y | All | 21 | 58 | 21 | ||
| Altissimi** | 1991 | 54 | 35 y | 4–64 y | — | 1–7 y | — | 26 | 61 | 13 | ||
| Chow | 1993 | 72 | — | >16 y | 2 y | 2 y | — | 10 | 65 | 25 | ||
| Eisenschenk | 1993 | 204 | 36 y | 16–68 y | 7.25 y | 1–15.5 y | All | 54 | 36 | 10 | ||
| Vertruyen | 1994 | 65 | 23 y | <20–60 y | 2.7 y | 1.2–5.4 y | — | 26 | 48 | 26 | ||
| Elias | 1994 | 83 | 30 y | 14–70 y | — | — | — | 6 | 64 | 30 | ||
| Tadjalli | 1995 | 37 | 32 y | — | 2.9 y | 1.3–7.25 y | — | 19 | 32 | 49 | ||
| Wang*** | 1996 | 76 | — | 18–79 y | — | ≥1 y | All | 16 | 37 | 47 | ||
| Malizos | 1997 | 25 | 37 y | 19–61 y | 2.3 y | 1.7–4.3 y | — | 8 | 72 | 20 | ||
| Schenker | 2006 | 5 | 30 y | 17–51 y | 1.2 y | 0.75–1.5 y | — | 0 | 60 | 40 | ||
| Sommer | 2009 | 53 | 42 y | 15–85 y | 4.2 y | 1.3–7.3 y | All | 18 | 40 | 42 | ||
Listings of treatment, author, publication date (pub. date), nerves with follow-up, age (mean and range; y: year), follow-up time (mean and range), timing of repair (all: primary and secondary; prim.: primary), sensory recovery (S0–3, S3+, and S4), and Glickman and Mackinnon [25] (+: publication already mentioned in Glickman and Mackinnon [25]); ∗: children ≤14 y/not 100% conform with the Highet classification/3–5 mm: 14 patients/6–15 mm: 4 patients/16–25 mm: 0 patients/patients with S4 could be less; ∗∗: not 100% conform with the Highet classification/≤5 mm: 7 patients/6–10 mm: 20 patients/11–15 mm: 13 patients/>15 mm: 14 patients/patients with S4 could be less; ∗∗∗: not 100% conform with the Highet classification/≤7 mm: 36 patients/8–15 mm: 28 patients/>15 mm: 12 patients/patients with S4 could be more.